pI: 7.1076 |
Length (AA): 706 |
MW (Da): 83374 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
185 | 705 | 2bmb (A) | 353 | 861 | 25.00 | 0 | 1 | 0.68 | 0.1 |
385 | 617 | 1tx2 (A) | 16 | 228 | 40.00 | 0 | 1 | 0.79 | -0.98 |
74 | 255 | 4uos (A) | 2 | 177 | 23.00 | 0.00067 | 0.67 | 0.55819 | -0.93 |
310 | 690 | 4pzv (A) | 81 | 421 | 23.00 | 0 | 1 | 0.34296 | 1.36 |
380 | 702 | 1aj0 (A) | 6 | 271 | 32.00 | 0 | 1 | 0.609907 | -0.02 |
388 | 616 | 1ad1 (A) | 3 | 210 | 38.00 | 0 | 1 | 0.648263 | -0.09 |
74 | 255 | 4uos (A) | 2 | 177 | 23.00 | 0.00081 | 0.81 | 0.58709 | -1.07 |
123 | 706 | 3bof (A) | 1 | 560 | 12.00 | 0 | 1 | 0.515195 | 0.89 |
380 | 702 | 1aj0 (A) | 6 | 271 | 32.00 | 0 | 1 | 0.619807 | -0.11 |
388 | 616 | 1ad1 (A) | 3 | 210 | 38.00 | 0 | 1 | 0.651963 | -0.13 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 32 hs, early trophozoite, late ring, late trophozoite. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 48 hs, sporozoite, early ring, early schizont, Oocyst, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 40 hs, Male Gametocyte. | Otto TD Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Sporozoite, Female Gametocyte. | Zanghi G Lasonder E |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Ortholog group members (OG5_128803)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G30000 | Dihydropterin pyrophosphokinase / Dihydropteroate synthase |
Arabidopsis thaliana | AT1G69190 | bifunctional hydroxymethyldihydropterinpyrophosphokinase/ dihydropteroate synthase |
Candida albicans | CaO19.8210 | likely pterin binding enzyme similar to S. cerevisiae FOL1 (YNL256W) involved in folic acid and derivative biosynthesis |
Candida albicans | CaO19.579 | likely pterin binding enzyme similar to S. cerevisiae FOL1 (YNL256W) involved in folic acid and derivative biosynthesis |
Chlamydia trachomatis | CT_613 | bifunctional 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase/dihydropteroate synthase |
Dictyostelium discoideum | DDB_G0278283 | dihydro-6-hydroxymethylpterin pyrophosphokinase |
Escherichia coli | b3177 | 7,8-dihydropteroate synthase |
Mycobacterium leprae | ML0224 | Probable dihydropteroate synthase 1 FolP1 (DHPS 1) (dihydropteroate pyrophosphorylase 1) (dihydropteroate dipyrophosphorylase 1) |
Mycobacterium tuberculosis | Rv3608c | Dihydropteroate synthase 1 FolP (DHPS 1) (dihydropteroate pyrophosphorylase 1) (dihydropteroate diphosphorylase 1) |
Mycobacterium ulcerans | MUL_4190 | dihydropteroate synthase 1 FolP1 |
Neospora caninum | NCLIV_027230 | Dihydropteroate synthase, related |
Oryza sativa | 4343919 | Os07g0618500 |
Plasmodium berghei | PBANKA_1426700 | hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase, putative |
Plasmodium falciparum | PF3D7_0810800 | hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase |
Plasmodium knowlesi | PKNH_1429900 | hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase, putative |
Plasmodium vivax | PVX_123230 | hydroxymethylpterin pyrophosphokinase-dihydropteroate synthetase, putative |
Plasmodium yoelii | PY02225 | hypothetical protein |
Plasmodium yoelii | PY02226 | dihydropteroate synthase, putative |
Saccharomyces cerevisiae | YNL256W | trifunctional dihydropteroate synthetase/dihydrohydroxymethylpterin pyrophosphokinase/dihydroneopterin aldolase FOL1 |
Toxoplasma gondii | TGME49_259550 | dihydropteroate synthase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
b3177 | Escherichia coli | essential | goodall |
YNL256W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1426700 | Plasmodium berghei | Essential | plasmo |
TGME49_259550 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | decreased time (PATO:0000716) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | inferred from anti-sense experiment (ECO:0000018) | Plasmodium falciparum | No drug identifiers listed for this gene. |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 8552672 | |
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium falciparum | 513479 561569 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 15155224 9076734 9391132 | |
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium vivax | 513479 561569 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 15155224 9076734 9391132 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References | |
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Plasmodium berghei | hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase, putative | Compounds | References |
Escherichia coli | 7,8-dihydropteroate synthase | Compounds | References |
Bacillus anthracis | Dihydropteroate synthase | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bacteria | Bacterial dihydropteroate synthase | 282 aa | 27.5% | 316 aa | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
PF3D7_0810800 | purified protein | BRENDA | A protein with this EC number or name or sequence has been purified from Plasmodium chabaudi ( 4 ) |
136 literature references were collected for this gene.